Last reviewed · How we verify
BIO-11006 Inhalation Solution — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
BIO-11006 Inhalation Solution (BIO-11006 Inhalation Solution) — BioMarck Pharmaceuticals, Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BIO-11006 Inhalation Solution TARGET | BIO-11006 Inhalation Solution | BioMarck Pharmaceuticals, Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BIO-11006 Inhalation Solution CI watch — RSS
- BIO-11006 Inhalation Solution CI watch — Atom
- BIO-11006 Inhalation Solution CI watch — JSON
- BIO-11006 Inhalation Solution alone — RSS
Cite this brief
Drug Landscape (2026). BIO-11006 Inhalation Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/bio-11006-inhalation-solution. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab